Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31116643 | 1.00 | MAPT (0.60) | MAPTGAAPPARGALDH1A1LMNA | |
| Acetic Acid SCHEMBL28545152 | 0.91 | MAPT (0.65) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL2023989 | 0.90 | MAPT (0.67) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL2024527 | 0.88 | MAPT (0.61) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL2027463 | 0.86 | MAPT (0.55) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL2023141 | 0.86 | MAPT (0.54) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL1193308 | 0.85 | KMT2A (0.52) | MAPTGAAALDH1A1LMNATP53 | |
| SCHEMBL2022725 | 0.85 | MAPT (0.57) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL2028733 | 0.83 | MAPT (0.55) | MAPTGAAPPARGALDH1A1LMNA | |
| SCHEMBL3174413 | 0.82 | PPARG (0.48) | MAPTGAAPPARGALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073151-A2 | METHOD FOR THE TWO-STEP DYEING OF KERATIN FIBRES, BY APPLICATION OF A COMPOSITION COMPRISING A NAPHTALENE DERIVATIVE, THEN ALKALINE TREATMENT. | L'OREAL (FR) | 2011-06-23 | — | — | WO | claimed |
| EP-0850635-B1 | Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set | OREAL (FR) | 1999-07-14 | — | — | EP | claimed |
| EP-0850635-A1 | Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set | L'OREAL (FR) | 1998-07-01 | — | — | EP | claimed |
| CN-112645809-B | Novel coronavirus 3CL protease inhibitor based on menadione structure | 上海交通大学 | 2022-04-26 | — | — | CN | disclosed |
| CN-112645809-A | Novel coronavirus 3CL protease inhibitor based on menadione structure | 上海交通大学 | 2021-04-13 | — | — | CN | disclosed |
| WO-2011073151-A2 | METHOD FOR THE TWO-STEP DYEING OF KERATIN FIBRES, BY APPLICATION OF A COMPOSITION COMPRISING A NAPHTALENE DERIVATIVE, THEN ALKALINE TREATMENT. | L'OREAL (FR) | 2011-06-23 | — | — | WO | disclosed |
| US-7763740-B2 | Method for the production of mumbaistatin derivatives | SANOFI-AVENTIS (FR) | 2010-07-27 | — | — | US | disclosed |
| US-7763740-B2 | Method for the production of mumbaistatin derivatives | SANOFI-AVENTIS (FR) | 2010-07-27 | — | — | US | disclosed |
| EP-1555993-B1 | PERMANENT COLORING OF HAIR USING AN OXIDATION HAIR DYE PRECURSOR AND A METAL CYANATE | UNILEVER PLC (GB) | 2010-03-24 | — | — | EP | disclosed |
| US-20090156836-A1 | METHOD FOR THE PRODUCTION OF MUMBAISTATIN DERIVATIVES | SANOFI-AVENTIS (FR) | 2009-06-18 | — | — | US | disclosed |
| US-20090156836-A1 | METHOD FOR THE PRODUCTION OF MUMBAISTATIN DERIVATIVES | SANOFI-AVENTIS (FR) | 2009-06-18 | — | — | US | disclosed |
| WO-2004014328-A1 | ONE STEP HAIR COLORING COMPOSITIONS COMPRISING WATER SOLUBLE CARBONATE RELEASING SALTS | UNILEVER PLC (GB) | 2004-02-19 | — | — | WO | disclosed |
| US-20040019980-A1 | One step hair coloring compositions using salts | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-05 | — | — | US | disclosed |
| US-20030135935-A1 | Enhanced color deposition for hair with sequestering agents | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-07-24 | — | — | US | disclosed |
| WO-2003053386-A1 | ENHANCED COLOUR DEPOSITION FOR HAIR WITH SEQUESTERING AGENTS | UNILEVER PLC (GB) | 2003-07-03 | — | — | WO | disclosed |
| EP-0850635-B1 | Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set | OREAL (FR) | 1999-07-14 | — | — | EP | disclosed |
| US-5873910-A | IN FIRST STAGE APPLYING TO KERATIN FIBER A FIRST SOLUTION CONTAINING IN A DYEING MEDIUM A MANGANESE SALT AND/OR COMPLEX, IN SECOND STAGE, APPLYING TO THE HAIR A SOLUTION WHICH CONTAINS 4-SUBSTITUED NAPHTHOL/1-/ AND AN OXIDIZER | L'OREAL (FR) | 1999-02-23 | — | — | US | disclosed |
| EP-0850635-A1 | Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set | L'OREAL (FR) | 1998-07-01 | — | — | EP | disclosed |
| EP-0413224-A1 | Fungicidal agent containing 1,2-naphthoquinones | BASF Aktiengesellschaft (DE) | 1991-02-20 | — | — | EP | disclosed |
| US-4460681-A | COLOR FORMING LAYERS, AND SOLVENT SOLUBLE BARRIE LAYERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156836-A1 | METHOD FOR THE PRODUCTION OF MUMBAISTATIN DERIVATIVES | MMAB, MLYCD, HMBS | MAPT 4145/4885GAA 2160/4885PPARG 4523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.